SUBSCRIBE
SUBSCRIBE
News   Business

Ariad Pharmaceuticals, Inc. Reports First Quarter 2012 Financial Results and Development Progress

May 9, 2012 | 
1 min read

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today reported financial results for the first quarter ended March 31, 2012 and provided an update on corporate developments.

Earnings
MORE ON THIS TOPIC
Cigna Healthcare office in Delaware
Pharmacy benefit managers
Cigna Continues Biosimilar Push, Targets J&J’s Stelara With No Out-of-Pocket Cost
September 6, 2024
 · 
2 min read
 · 
Tristan Manalac
Pictured: Novartis' logo outside its building in S
Manufacturing
Novartis Starts Construction on Two US Sites to Bolster Radioligand Therapy Manufacturing
September 5, 2024
 · 
2 min read
 · 
Tristan Manalac
Business growth concept. Vector of a business man hand with pot watering profitable money tree
Business
ArsenalBio Snags Mega $325M Series C Round With Backing from Nvidia, Regeneron
September 4, 2024
 · 
1 min read
 · 
Annalee Armstrong
Pictured: Nasdaq headquarters in New York/iStock,
IPO
Lilly Partner BioAge Files for IPO to Advance Obesity Candidate
September 4, 2024
 · 
2 min read
 · 
Tristan Manalac